PUBLISHER: Polaris Market Research | PRODUCT CODE: 1807440
PUBLISHER: Polaris Market Research | PRODUCT CODE: 1807440
The flow cytometry market size is expected to reach USD 9.98 billion by 2034, according to a new study by Polaris Market Research. The report "Flow Cytometry Market Share, Size, Trends, Industry Analysis Report By Offering (Instruments, Reagents & Consumables, Software, Accessories, Service), By Technology, By Application, By End Use, By Region; Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.
Flow cytometry is a powerful analytical technique used to measure and analyze the physical and chemical characteristics of cells or particles suspended in a fluid. The process involves passing a stream of single cells through a laser beam, where they scatter light and emit fluorescence, which is then detected by photomultiplier tubes. The scattered light provides information about cell size and granularity, while fluorescence markers such as fluorochrome-labeled antibodies or dyes allow the detection of specific proteins, DNA content, or other intracellular components. Modern flow cytometers can analyze thousands of cells per second, providing high-throughput, multiparametric data.
Flow cytometry has diverse applications in research, clinical diagnostics, and therapeutics. In immunology, it is widely used for immunophenotyping, where cell populations are identified and quantified based on surface or intracellular markers, aiding in the study of immune responses and diseases such as HIV or leukemia. Flow cytometry in cancer research helps in DNA content analysis, cell cycle profiling, and detecting minimal residual disease. It also plays a critical role in stem cell research, enabling the isolation of specific cell types using fluorescence-activated cell sorting (FACS), a specialized form of flow cytometry.
In terms of offering, the instruments segment accounted for 36.24% of the revenue share in 2024 due to widespread adoption of advanced cell analysis technologies across clinical, research, and industrial applications.
Based on technology, the cell-based segment held 75.42% of revenue share in 2024 due to its broad application in immunology, oncology, and infectious disease research.
Based on end use, the clinical segment accounted for 43.16% of revenue share in 2024 due to increasing demand for precise diagnostic tools in hematology, oncology, and infectious disease management.
North America accounted for a 42.15% share of the global flow cytometry market revenue in 2024. This dominance is attributed to strong investments in biomedical research, a high prevalence of chronic diseases such as cancer and HIV, and advanced healthcare infrastructure.
The industry in Asia Pacific is projected to grow at the fastest pace in the coming years, owing to increasing healthcare expenditure, rising prevalence of infectious and chronic diseases.
A few global key players in the flow cytometry market include Agilent Technologies, Inc.; Apogee Flow Systems Ltd.; BD; Bio-Rad Laboratories, Inc.; Cytek Biosciences; DH Life Sciences, LLC; Miltenyi Biotec; Sony Biotechnology Inc.; Stratedigm, Inc.; Sysmex Corporation; and Thermo Fisher Scientific, Inc.
Polaris Market Research has segmented the flow cytometry market report on the basis of offering, technology, application, end use, and region:
By Offering Outlook (Revenue, USD Billion, 2020-2034)
Instruments
Reagents & Consumables
Software
Accessories
Service
By Technology Outlook (Revenue, USD Billion, 2020-2034)
Cell-based
Bead-based
By Application Outlook (Revenue, USD Billion, 2020-2034)
Research
Industrial
Clinical
By End Use Outlook (Revenue, USD Billion, 2020-2034)
Commercial Organizations
Hospitals
Academic Institutes
Clinical Testing Labs
By Regional Outlook (Revenue, USD Billion, 2020-2034)
North America
U.S.
Canada
Europe
Germany
France
UK
Italy
Spain
Netherlands
Russia
Rest of Europe
Asia Pacific
China
Japan
India
Malaysia
South Korea
Indonesia
Australia
Vietnam
Rest of Asia Pacific
Middle East & Africa
Saudi Arabia
UAE
Israel
South Africa
Rest of Middle East & Africa
Latin America
Mexico
Brazil
Argentina
Rest of Latin America